Relmada Therapeutics Inc has split its stock 2 times since its initial public offering (IPO). The first stock split occurred on August 12, 2015 with the ratio of 1-for-5, meaning that for 5 shares of RLMD owned pre-split, shareholders then owned 1 share. The most recent stock split took place on September 30, 2019 on a 1-for-4 basis.
These actions have increased RLMD stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that a stock split only change the number of shares and the price per share with no impact on Relmada Therapeutics Inc's total market capitalization.
For more detailed information of Relmada Therapeutics Inc's stock splits, view the table below:
The answer will depend on the decisions of the company's managers and market volatility. Relmada Therapeutics Inc has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when RLMD stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Relmada Therapeutics Inc's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.
